-+ 0.00%
-+ 0.00%
-+ 0.00%

Elicio Therapeutics Added To Russell 2000, 3000 Indexes, Effective June 26

Benzinga·06/29/2026 12:03:58
Listen to the news

Elicio Therapeutics, Inc. (Nasdaq: ELTX) ("Elicio" or the "Company"), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that the Company was added to the Russell 2000® and Russell 3000® Indexes, effective after the U.S. market close on June 26, 2026, as part of the 2026 Russell indexes annual reconstitution.